Amid climbing infection rates among children, pediatricians are bracing for a crush as Pfizer moves toward offering vaccine for children ages 5 to 11.
Amid climbing infection rates among children, pediatricians are bracing for a crush as Pfizer moves toward offering vaccine for children ages 5 to 11.